Novel CD37, Humanized CD37 and Bi-Specific Humanized CD37-CD19 CAR-T Cells Specifically Target Lymphoma

Golubovskaya, V; Zhou, H; Li, F; Valentine, M; Sun, JY; Berahovich, R; Xu, S; Quintanilla, M; Ma, MC; Sienkiewicz, J; Huang, YW; Wu, LJ

Golubovskaya, V; Wu, LJ (corresponding author), Promab Biotechnol, 2600 Hilltop Dr, Richmond, CA 94806 USA.; Wu, LJ (corresponding author), Forevertek Biotechnol, Changsha Hitech Ind Dev Zone, Janshan Rd, Changsha 410205, Peoples R China.

CANCERS, 2021; 13 (5):

Abstract

Simple Summary Chimeric antigen receptor (CAR) T cell therapy represents a major advancement in cancer treatment. Recently, FDA approved CAR-T cells d......

Full Text Link